Loopbaan van William Fricker
Eerdere bekende functies van William Fricker
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Financieel Directeur/CFO | 01-01-2022 | 01-01-2023 |
| NRX PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 24-05-2021 | 30-08-2021 |
| Treasurer | 24-05-2021 | 30-08-2021 | |
| IMMUNOMEDICS, INC. | Comptroller/Controller/Auditor | 23-08-2018 | 01-10-2020 |
J. M. Huber Micropowders, Inc.
 J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Comptroller/Controller/Auditor | - | - |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
Sectoraal
| Health Technology | 4 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
J. M. Huber Micropowders, Inc.
J. M. Huber Micropowders, Inc. Chemicals: SpecialtyProcess Industries Part of J. M. Huber Corp., J. M. Huber Micropowders, Inc. is a company that manufactures chemicals and minerals. The company is based in Edison, NJ. The CEO of the company is Matthew O'Brien. | Process Industries |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Beurs
- Insiders
- William Fricker
- Ervaring
